PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Cardioprotective Effects of Latifolin Against Doxorubicin-Induced Cardiotoxicity by Macrophage Polarization in Mice.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32217949 ↗2020Reported benefit

Cardioprotective Effects of Latifolin Against Doxorubicin-Induced Cardiotoxicity by Macrophage Polarization in Mice.

MouseChemical/toxinC57BL/6Malen = 16 mice per group in four groups; n = 6 for LDH, n = 8 for…Oral, suspended in 0.5 per cent sodium carboxymethyl cellulose50 mg/kg or 100 mg/kg orally in vivo; 1.25, 2.5, 5 and 10 m…Oral latifolin started 4 days before the doxorubicin injection, which was given…

Model: Doxorubicin-induced cardiotoxicity, single intraperitoneal dose of doxorubicin 20 mg/kg on day 5

Latifolin at 100 mg/kg significantly reduced cardiac LDH, improved left ventricular ejection fraction and fractional shortening, and preserved myocardial architecture. It decreased myocardial iNOS and CD86 expression and increased CD206, IL-10 and IL-4R. In cultured peritoneal macrophages latifolin…

Extraction: extract · Supplied extraction confidence: 0.92. Machine-extracted fields require source verification.